Home • Projects • Liraglutide – Next-Generation Antidiabetic Medication

Novo Nordisk’s repaglinide (NovoNorm) is an oral antidiabetic agent for the treatment of type 2 diabetes in patients who uncontrolled by diet and exercise.

«Back

---

Home | New On This Site | Products & Services | Company A-Z | Industry Projects | White Papers | Jobs & Careers | Press Releases | Events & Exhibitions | Newsletter | Organisations | About Us | Contact Us | Advertise With Us |